NasdaqGM - Delayed Quote USD
Structure Therapeutics Inc. (GPCR)
21.68
-0.54
(-2.43%)
At close: 4:00:00 PM EDT
21.42
-0.26
(-1.20%)
After hours: 4:37:16 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 4.72M | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| STEVENS RAYMOND C Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 14, 2025 |
| HALL ASHLEY Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 14, 2025 |
| LIN XICHEN Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 14, 2025 |
| YOON JUN Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 14, 2025 |
| COLL CRESPO BLAS Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 14, 2025 |
| HALL ASHLEY Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Sep 18, 2024 |
| COLL CRESPO BLAS Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Sep 18, 2024 |
| LIN XICHEN Officer | Conversion of Exercise of derivative security at price 52.74 per share. | Direct | 5,600,988 | Jun 3, 2024 |
| LIN XICHEN Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 15, 2024 |
| BACH MARK ALLEN Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 15, 2024 |
Related Tickers
TERN Terns Pharmaceuticals, Inc.
3.8800
-1.27%
MGX Metagenomi, Inc.
1.4300
-1.38%
MLTX MoonLake Immunotherapeutics
44.21
+0.43%
MTSR Metsera, Inc.
29.38
-15.04%
AKRO Akero Therapeutics, Inc.
55.62
+3.85%
CYTK Cytokinetics, Incorporated
34.38
+3.55%
VKTX Viking Therapeutics, Inc.
26.08
-8.75%
ETNB 89bio, Inc.
10.41
+8.21%
MDGL Madrigal Pharmaceuticals, Inc.
295.57
-0.55%
NRIX Nurix Therapeutics, Inc.
11.93
-0.25%